Virax Biolabs Group Limited - VRAX
About Gravity Analytica
Recent News
- 04.24.2025 - Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmaExec.com Interview.
- 04.24.2025 - Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmaExec.com Interview.
- 04.23.2025 - In His Latest PharmaExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.
- 04.23.2025 - In His Latest PharmaExec Interview, Virax COO Dr Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.
- 04.17.2025 - Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.
- 03.18.2025 - Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
- 03.18.2025 - Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
- 03.13.2025 - Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
- 03.13.2025 - Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
- 03.12.2025 - Virax Biolabs Presentation from the 19th World Immune Regulation Meeting: “Evaluation of T cell dysfunction in Post Acute Infection Syndromes”